Antigen-specific CD4

CD4+ T cell SARS-CoV-2 T follicular helper cell lymph node mRNA vaccination

Journal

Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035

Informations de publication

Date de publication:
15 Sep 2023
Historique:
pubmed: 4 10 2023
medline: 4 10 2023
entrez: 4 10 2023
Statut: epublish

Résumé

SARS-CoV-2 infection and mRNA vaccination induce robust CD4

Identifiants

pubmed: 37790414
doi: 10.21203/rs.3.rs-3304466/v1
pmc: PMC10543502
pii:
doi:

Types de publication

Preprint

Langues

eng

Auteurs

Philip Mudd (P)

Washington University School of Medicine.

Nicholas Borcherding (N)

Washington University.

Wooseob Kim (W)

Korea University College of Medicine.

Michael Quinn (M)

Washington University School of Medicine.

Fangjie Han (F)

Washington University School of Medicine.

Julian Zhou (J)

Washington University in St Louis.

Alexandria Sturtz (A)

Washington University School of Medicine.

Aaron Schmitz (A)

Washington University School of Medicine.

Tingting Lei (T)

Washington University School of Medicine.

Stefan Schattgen (S)

St Jude Children's Research Hospital.

Michael Klebert (M)

Washington University School of Medicine.

Teresa Suessen (T)

Washington University School of Medicine.

William Middleton (W)

Washington University School of Medicine.

Charles Goss (C)

Division of Biostatistics, Washington University in St.Louis.

Chang Liu (C)

Washington University School of Medicine.

Jeremy Crawford (J)

St Jude Children's Research Hospital.

Paul Thomas (P)

St. Jude Children's Research Hospital.

Sharlene Teefey (S)

Washington University School of Medicine.

Rachel Presti (R)

Washington University School of Medicine.

Jane O'Halloran (J)

Department of Emergency Medicine, Washington University in St.Louis.

Jackson Turner (J)

Washington University School of Medicine.

Ali Ellebedy (A)

Washington University School of Medicine.

Classifications MeSH